COVID-19 vaccination guidelines for patients with multiple sclerosis

The opinion of Russian experts on the possibility of COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number of domestic and foreign guidelines, conclude that it is possible to use killed and inactivated vaccine...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nevrologii͡a︡, neĭropsikhiatrii͡a︡, psikhosomatika neĭropsikhiatrii͡a︡, psikhosomatika, 2021-04, Vol.13 (2), p.157-161
Hauptverfasser:	Khachanova, N. V., Totolyan, N. A., Vlasov, Ya. V., Sivertseva, S. A., Davydovskaya, M. V., Evdoshenko, E. P., Prodeus, A. P., Zakharova, M. N., Spirin, N. N., Boyko, A. N.
Format:	Artikel
Sprache:	eng ; rus
Schlagworte:	covid-19 vaccination disease modifying therapies infections multiple sclerosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The opinion of Russian experts on the possibility of COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number of domestic and foreign guidelines, conclude that it is possible to use killed and inactivated vaccines. Preliminary recommendations are given for COVID-19 vaccination, taking into account the MS disease modifying therapies.
ISSN:	2074-2711 2310-1342
DOI:	10.14412/2074-2711-2021-2-157-161